Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE vs IPCA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES PHARMA SCIENCE IPCA LABS STRIDES PHARMA SCIENCE/
IPCA LABS
 
P/E (TTM) x -1,455.3 51.7 - View Chart
P/BV x 3.3 5.4 61.0% View Chart
Dividend Yield % 0.2 0.3 59.3%  

Financials

 STRIDES PHARMA SCIENCE   IPCA LABS
EQUITY SHARE DATA
    STRIDES PHARMA SCIENCE
Mar-23
IPCA LABS
Mar-23
STRIDES PHARMA SCIENCE/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs3921,062 36.9%   
Low Rs263768 34.3%   
Sales per share (Unadj.) Rs408.5243.0 168.1%  
Earnings per share (Unadj.) Rs-25.619.4 -131.9%  
Cash flow per share (Unadj.) Rs1.429.7 4.6%  
Dividends per share (Unadj.) Rs1.504.00 37.5%  
Avg Dividend yield %0.50.4 104.7%  
Book value per share (Unadj.) Rs242.8230.3 105.5%  
Shares outstanding (eoy) m90.30253.70 35.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.83.8 21.3%   
Avg P/E ratio x-12.847.2 -27.2%  
P/CF ratio (eoy) x239.630.8 777.9%  
Price / Book Value ratio x1.44.0 34.0%  
Dividend payout %-5.920.6 -28.4%   
Avg Mkt Cap Rs m29,603232,120 12.8%   
No. of employees `000NANA-   
Total wages/salary Rs m7,32012,876 56.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m36,88461,642 59.8%  
Other income Rs m1,3521,518 89.1%   
Total revenues Rs m38,23663,160 60.5%   
Gross profit Rs m8309,033 9.2%  
Depreciation Rs m2,4332,616 93.0%   
Interest Rs m2,611482 541.9%   
Profit before tax Rs m-2,8627,453 -38.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-5532,534 -21.8%   
Profit after tax Rs m-2,3094,919 -46.9%  
Gross profit margin %2.214.7 15.4%  
Effective tax rate %19.334.0 56.8%   
Net profit margin %-6.38.0 -78.4%  
BALANCE SHEET DATA
Current assets Rs m31,35351,893 60.4%   
Current liabilities Rs m29,90218,058 165.6%   
Net working cap to sales %3.954.9 7.2%  
Current ratio x1.02.9 36.5%  
Inventory Days Days7151 138.9%  
Debtors Days Days1296 2,195.7%  
Net fixed assets Rs m31,30034,336 91.2%   
Share capital Rs m903254 355.9%   
"Free" reserves Rs m21,02558,167 36.1%   
Net worth Rs m21,92858,420 37.5%   
Long term debt Rs m11,3986,518 174.9%   
Total assets Rs m63,73486,229 73.9%  
Interest coverage x-0.116.5 -0.6%   
Debt to equity ratio x0.50.1 465.9%  
Sales to assets ratio x0.60.7 81.0%   
Return on assets %0.56.3 7.6%  
Return on equity %-10.58.4 -125.0%  
Return on capital %-0.812.2 -6.2%  
Exports to sales %46.742.9 108.8%   
Imports to sales %013.3 0.0%   
Exports (fob) Rs m17,21326,434 65.1%   
Imports (cif) Rs mNA8,178 0.0%   
Fx inflow Rs m18,11326,434 68.5%   
Fx outflow Rs m6728,178 8.2%   
Net fx Rs m17,44218,257 95.5%   
CASH FLOW
From Operations Rs m4448,058 5.5%  
From Investments Rs m3,025-7,250 -41.7%  
From Financial Activity Rs m-2,1395,072 -42.2%  
Net Cashflow Rs m1,3285,881 22.6%  

Share Holding

Indian Promoters % 27.4 46.3 59.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 38.9 44.8 86.8%  
FIIs % 19.5 10.3 189.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 72.6 53.7 135.2%  
Shareholders   91,182 82,809 110.1%  
Pledged promoter(s) holding % 69.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES PHARMA SCIENCE With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on STRIDES PHARMA SCIENCE vs IPCA Labs

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

STRIDES PHARMA SCIENCE vs IPCA Labs Share Price Performance

Period STRIDES PHARMA SCIENCE IPCA Labs S&P BSE HEALTHCARE
1-Day 1.16% 3.35% 1.18%
1-Month 0.35% 4.27% -0.75%
1-Year 176.88% 56.49% 61.82%
3-Year CAGR -3.35% 9.46% 18.16%
5-Year CAGR 10.98% 20.88% 19.79%

* Compound Annual Growth Rate

Here are more details on the STRIDES PHARMA SCIENCE share price and the IPCA Labs share price.

Moving on to shareholding structures...

The promoters of STRIDES PHARMA SCIENCE hold a 27.4% stake in the company. In case of IPCA Labs the stake stands at 46.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of STRIDES PHARMA SCIENCE and the shareholding pattern of IPCA Labs.

Finally, a word on dividends...

In the most recent financial year, STRIDES PHARMA SCIENCE paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of -5.9%.

IPCA Labs paid Rs 4.0, and its dividend payout ratio stood at 20.6%.

You may visit here to review the dividend history of STRIDES PHARMA SCIENCE, and the dividend history of IPCA Labs.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.